Risk factor
Very poor trading liquidity
Profitability factor
Favourable analyst view
About
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia,...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is neutral on EV/EBITDA, reasonably pr
Target Price
The average target price of NAVA.OL is 36 and suggests 64% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
Buy
Sell